Results 181 to 190 of about 30,077 (242)

Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo.

open access: green, 1991
Kevin J. Gilligan   +7 more
openalex   +2 more sources

Heterogeneity of HLA and EBER expression in epstein-barr virus-associated nasopharyngeal carcinoma [PDF]

open access: bronze, 2000
Yunhong Yao   +5 more
openalex   +1 more source

Tumor–Stroma Ratio in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta‐Analysis

open access: yesOral Diseases, EarlyView.
ABSTRACT Background Tumor‐stroma ratio (TSR) has been recognized as a significant prognostic factor in various cancers. This systematic review evaluates the role of TSR in head and neck squamous cell carcinoma (HNSCC) and its association with patient outcomes such as overall survival (OS), disease‐free survival (DFS), disease‐specific survival (DSS ...
Gennaro Musella   +6 more
wiley   +1 more source

Results of chemo-radiotherapy for nasopharyngeal carcinoma.

open access: bronze, 1991
Gentaro Mizojiri   +5 more
openalex   +2 more sources

Follicular Dendritic Cell Sarcoma of the Parapharyngeal Space Arising in Association With Castleman Disease

open access: yesPathology International, EarlyView.
Histopathological and immunohistochemical findings from the excisional biopsy of a right parapharyngeal mass in a 56‐year‐old woman with follicular dendritic cell sarcoma arising in Castleman disease. (A) H&E staining reveals atypical tumor cells intimately admixed with lymphocytes. (B) Adjacent areas show “lollipop lesions” characteristic of Castleman
Shunsuke Koga   +3 more
wiley   +1 more source

Cancer incidence and stage at diagnosis in children and adolescents in the Community of Madrid, 2015–2018

open access: yesPaediatric and Perinatal Epidemiology, EarlyView.
Abstract Background Cancer is the leading cause of death in children aged 1–14 and the second in 15‐19‐year‐old adolescents in Spain. The Paediatric Population‐Based Cancer Registry of the Community of Madrid was created to monitor its incidence and survival.
Raquel López‐González   +5 more
wiley   +1 more source

Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial

open access: yesCA: A Cancer Journal for Clinicians, EarlyView.
Abstract Background Nearly 90% locoregionally advanced nasopharyngeal carcinoma (LANPC) responds to induction chemotherapy (IC) with significant tumor volume shrinkage. Radiotherapy always follows IC, and reduced volume has been proposed. However, the efficacy and safety of reduced‐volume radiotherapy is uncertain.
Ling‐Long Tang   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy